GP5 and cervical carcinoma: With respect to the most carcinogenic HPV types relevant for cervical cancer screening, we found that 55% of HPV16‐positives and 30% of HPV18‐positives by GP5+/6+ PCR‐based genotyping were also detected by careHPV, which compares with 46% of HPV16 and 49% of HPV18 INNO‐LiPA–positive samples, respectively.33